[Today's focus]

Shijiyao Group (02005.HK): Net profit increased 14.6% to HK$416 million in the first quarter

Shijiyao Group (02005.HK) announced that the Group's sales are mainly carried out in China and are denominated in RMB. For the three months ending March 31, 2024, the RMB depreciated by about 3.6% against the Hong Kong dollar compared to the same period in 2023. As a result, in Hong Kong dollars, the Group's unaudited turnover for the three months ended 31 March 2024 increased by only 2.9% over the same period in 2023 to approximately HK$1,799 billion (same period in 2023: approximately HK$1,749 million). Unaudited gross profit increased by 2.3% to approximately HK$1,031 million (same period in 2023: approximately HK$1,008 billion). Unaudited gross margin was approximately 57.3%, a slight decrease of 0.3 percentage points from the same period in 2023. Profit attributable to shareholders of unaudited companies increased by approximately 14.6% over the same period in 2023 to approximately HK$416 million (same period in 2023: approximately HK$363 million).

[Important matters]

Honghua Group (00196.HK) subsidiary and CCCC First Shipping signed a material sales contract of about 320 million yuan

Yingsheng Science (00209.HK) plans to establish a subsidiary to develop new medical aesthetic market business

Hongxin Construction and Development (09930.HK) aerial work platform management scale was further expanded, and the total number reached about 190,000 units

Fussen Pharmaceutical (01652.HK) plans to establish a limited partnership to explore diversified business development

[Financial results]

Beijing Holdings (00392.HK): Yanjing Brewery's 2023 net profit increased 83.02% to 645 million yuan

Kingdee International (00268.HK): As of March 31, the annual recurring revenue (ARR) of Kingdee Cloud subscription services reached 2.98 billion yuan, an increase of about 28% year-on-year

Yuandong Hongxin (03360.HK)'s first quarter revenue and profit attributable to shareholders declined year-on-year

[Operational data]

China Coal Energy (01898.HK)'s commercial coal sales in March fell 16.9% year-on-year to 23.97 million tons

Shantao New Energy (01250.HK) completed power generation capacity of about 488,800 megawatt-hours in January, up about 16.2% year-on-year

Kingsley Biotechnology (01548.HK): CARVYKTI's net trade sales in the first quarter were about US$157 million

China Electric Power (02380.HK)'s consolidated total electricity sales volume of 10.55 million megawatt-hours in March increased 25.31% year-on-year

Mingfa Group (00846.HK)'s total contract sales for the first quarter were about 890 million yuan, down about 59.4% year on year

[Pharmaceutical Innovation]

Kangzhe Pharmaceutical (00867.HK): Lucotinib phosphate cream approved for marketing as a new drug in Macau

Shengnuo Pharmaceutical-B (02257.HK): Further development of STP705 for the treatment of squamous cell carcinoma in situ obtained specific guidance from the FDA

[Acquisition and sale]

Yuexiu Real Estate (00123.HK) subsidiary successfully competed for a plot in Zhongxing Community in Jing'an District, Shanghai with 1,597 billion yuan

Adults International (01957.HK): MBV Capital sells a total of 31.4 million company shares

[Issuance of additional shares]

Guanli Holdings (01872.HK) proposes a “10 in 1” merger

[Increase or decrease holdings]

China Railway Construction (01186.HK): China Railway Construction Group's plan to increase its holdings by a total of 13.58 million shares and a plan to increase its A-share holdings has been completed

[Repurchase Cancellation]

Meituan-W (03690.HK) spent HK$400 million to buy back 4.02 million shares on April 16

Changshi Group (01113.HK) spent HK$76.327 million to repurchase 2,434,500 shares on April 16

Shell-W (02423.HK) spent $10 million to buy back 2.302,700 shares on April 15

Standard Chartered Group (02888.HK) spent £8.09 million to buy back 1.05 million shares on April 15

Hang Seng Bank (00011.HK) spent HK$57.36 million to repurchase 600,000 shares on April 16

Xiaomi Group-W (01810.HK) spent HK$47.83 million to buy back 3 million shares on April 16

China Software International (00354.HK) spent HK$358.968 million to buy back 8 million shares on April 16

CSPC Group (01093.HK) spent HK$29.082 million to buy back 5 million shares on April 16

Shunyu Optical Technology (02382.HK) spent HK$24.54 million to buy back 660,000 shares on April 16

Kuaishou-W (01024.HK) spent HK$235.845 million to buy back 503,300 shares on April 16

Sansheng Pharmaceutical (01530.HK) spent HK$20.315 million to buy back 3.537 million shares on April 16

Pharmaceutical Biotech (02269.HK) spent HK$19.89 million to buy back 1.51 million shares on April 16

Tourover-W (09690.HK) spent HK$16.467 million to buy back 930,000 shares on April 16

Dongfeng Group shares (00489.HK) spent HK$15.59 million to buy back 5.72 million shares on April 16

China Biopharmaceutical (01177.HK) spent HK$12.7 million to buy back 5 million shares on April 16

Jiangxi Copper Co., Ltd. (00358.HK) spent 8.81 million yuan to buy back 341,500 A shares on April 16

Skyworth Group (00751.HK) spent HK$8.6417 million to repurchase 2,842 million shares on April 16

Kingdee International (00268.HK) spent HK$7.7397 million to buy back 975,000 shares on April 16

Zhou Heiya (01458.HK) spent HK$5.56 million to buy back 3.32 million shares on April 16

On April 16, Gushengtang (02273.HK) spent HK$5.247 million to buy back 130,000 shares

Jiufang Wealth (09636.HK) spent HK$5.175,300 to buy back 529,500 shares on April 16

AIA (01299.HK) spent HK$4.576 million to buy back 100,000 shares on April 16

Yum China (09987.HK) spent HK$4.66 million to buy back 15,800 shares on April 15

Times Electric (03898.HK): 4.696,800 shares have been cancelled and H shares have been repurchased